Sonoma Pharmaceuticals, Inc.

US$1.11As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SNOAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (47.59%)
Div yield —
ROE (42.52%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.31
PE TTM —
TSR TTM (71.83%)
Mkt cap US$5.315M
ROIC (14.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.26
13.51%
50.18%
Hold 0|7|7|0|1
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.01
0.01
0.01
0.01
23.29%
17.48%
23.06%
17.08%
Revenue$M
0.358
0.359
0.371
0.376
(0.44%)
1.17%
6.07%
7.54%
Peers (US$5.315M)
Cap (US$)
PE
4.661M
—
Capital
TTM
5Y
10Y
Leveragex
1.459
(0.454)
(0.393)
EBIT/Intx
0.222
0.134
0.191
Own earn%
21.11
101.38
108.33
Sh yield%
29.49
50.72
50.91
Owners
Insiders/Inst%
0.36
38.40
Short interest%
4.16
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
3